相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Simeprevir Increases Rate of Sustained Virologic Response Among Treatment-Experienced Patients With HCV Genotype-1 Infection: A Phase IIb Trial
Stefan Zeuzem et al.
GASTROENTEROLOGY (2014)
Simeprevir With Peginterferon and Ribavirin Leads to High Rates of SVR in Patients With HCV Genotype 1 Who Relapsed After Previous Therapy: A Phase 3 Trial
Xavier Forns et al.
GASTROENTEROLOGY (2014)
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Ira M. Jacobson et al.
LANCET (2014)
Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial
Michael Manns et al.
LANCET (2014)
The burden of hepatitis C in Europe from the patients' perspective: a survey in 5 countries
Jeffrey Vietri et al.
BMC GASTROENTEROLOGY (2013)
Once-Daily Simeprevir (TMC435) With Pegylated Interferon and Ribavirin in Treatment-Naive Genotype 1 Hepatitis C: The Randomized PILLAR Study
Michael W. Fried et al.
HEPATOLOGY (2013)
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
Khayriyyah Mohd Hanafiah et al.
HEPATOLOGY (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
INTERVIEWS WITH PATIENTS WITH CHRONIC HEPATITIS C (CHC) VIRUS INFECTION DOCUMENT UNMET NEEDS, CONTENT VALIDITY, AND COMPREHENSION OF PROS FOR CLINICAL TRIALS
S. Blackburn et al.
VALUE IN HEALTH (2013)
Chronic HCV infection: epidemiological and clinical relevance
S. Zaltron et al.
BMC INFECTIOUS DISEASES (2012)
The Burden of Untreated Hepatitis C Virus Infection: A US Patients' Perspective
Antoine C. El Khoury et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
The burden of viral hepatitis C in Europe: a propensity analysis of patient outcomes
Marco daCosta DiBonaventura et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver
Vincent Leroy et al.
LIVER INTERNATIONAL (2012)
The Burden of Illness for Patients with Viral Hepatitis C: Evidence from a National Survey in Japan
Gordon G. Liu et al.
VALUE IN HEALTH (2012)
An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
Marc G. Ghany et al.
HEPATOLOGY (2011)
The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities
Marco daCosta DiBonaventura et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
Telaprevir for Previously Treated Chronic HCV Infection.
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Validity of the work productivity and activity impairment questionnaire - general health version in patients with rheumatoid arthritis
Wei Zhang et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
Health-state utilities in liver disease: A systematic review
David J. McLernon et al.
MEDICAL DECISION MAKING (2008)
Assessment of the PHQ-9 as a screening tool for depression in patients with chronic hepatitis C
Nader Dbouk et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Depression, anemia and health-related quality of life in chronic hepatitis C
AA Dan et al.
JOURNAL OF HEPATOLOGY (2006)
Fatigue in the general population: A translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale
A Lerdal et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2005)
A comparison of health utility measures for the evaluation of multiple sclerosis treatments
JD Fisk et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Screening for depression in a hepatitis C population: the reliability and validity of the Center for Epidemiologic Studies Depression Scale (CES-D)
CH Clark et al.
JOURNAL OF ADVANCED NURSING (2002)
Emotional distress in chronic hepatitis C patients not receiving antiviral therapy
RJ Fontana et al.
JOURNAL OF HEPATOLOGY (2002)
Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients
D Bernstein et al.
HEPATOLOGY (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Depression, fatigue, and functional disability in patients with chronic hepatitis C
MM Dwight et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2000)
Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C
L Kleinman et al.
QUALITY OF LIFE RESEARCH (2000)
分享论文
